I-Mab Biopharma
IMAB
#9469
Rank
A$91.66 M
Marketcap
$1.12
Share price
-6.87%
Change (1 day)
-58.84%
Change (1 year)

Earnings for I-Mab Biopharma (IMAB)

Earnings in 2024 (TTM): -A$0.29 Billion

According to I-Mab Biopharma's latest financial reports the company's current earnings are A$3.58 Million. In 2023 the company made an earning of -A$48.36 Million, an increase over its 2022 earnings that were of -A$87.13 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for I-Mab Biopharma from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.29 Billion498.8%
2023 -A$48.36 Million-44.5%
2022-A$87.13 Million-8.36%
2021-A$95.08 Million-605.96%
2020 A$18.79 M-138.32%
2019 -A$49.04 Million260.14%
2018 -A$13.62 Million19.49%
2017-A$11.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$30.04 Million-90.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$17.15 Million-94.74%๐Ÿ‡บ๐Ÿ‡ธ USA